Teza Capital Management LLC Nektar Therapeutics Transaction History

Teza Capital Management LLC

  • $809 Million
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 12, 2020
SELL
$16.59 - $24.79 $580,484 - $867,402
-34,990 Closed
0 $0
Q2 2020

Aug 10, 2020
BUY
$16.86 - $23.44 $589,931 - $820,165
34,990 New
34,990 $810,000
Q1 2020

May 11, 2020
SELL
$14.47 - $27.96 $836,235 - $1.62 Million
-57,791 Closed
0 $0
Q4 2019

Feb 12, 2020
BUY
$15.87 - $23.12 $917,143 - $1.34 Million
57,791 New
57,791 $1.25 Million

Others Institutions Holding NKTR

# of Institutions
140
Shares Held
135M
Call Options Held
32.8K
Put Options Held
55.5K
View Full List

About NEKTAR THERAPEUTICS

NKTR Quotes by TradingView
  • Ticker NKTR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 187,404,992
  • Market Cap $244M
  • Description
  • Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...
More about NKTR
Track This Portfolio

Track Teza Capital Management LLC Portfolio

Follow Teza Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Teza Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Teza Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email